AXIM BIOTECHNOLOGIES, INC. (AXIM) Gross margin 2015–2019
AXIM BIOTECHNOLOGIES, INC. (AXIM) gross margin by fiscal year — reported gross profit divided by reported revenue.
0.0%FY2019 · since FY2015: -2.5% → 0.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 0.0% | -95.6 pp |
| FY2018 | 95.6% | +85.7 pp |
| FY2017 | 9.9% | +237.4 pp |
| FY2016 | -227.5% | -225.0 pp |
| FY2015 | -2.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross profitAXIM Operating incomeAXIM Operating marginAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →